Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-20

FDA Approved: MYXREDLIN — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved MYXREDLIN (insulin human) from Baxter Healthcare Corporation through an original application for use in the treatment of diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYXREDLIN (INSULIN HUMAN)

Snippet

ORIG AP for MYXREDLIN (INSULIN HUMAN)